↓ Skip to main content

Clinical, Biological and Molecular Aspects of COVID-19

Overview of attention for book
Attention for Chapter: SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.
Book title
Clinical, Biological and Molecular Aspects of COVID-19
Published in
Advances in experimental medicine and biology, March 2021
DOI 10.1007/978-3-030-59261-5_1
Pubmed ID
Book ISBNs
978-3-03-059260-8, 978-3-03-059261-5
Authors

Van Vo, Giau, Bagyinszky, Eva, Park, Yoon Soo, Hulme, John, An, Seong Soo A, Giau Van Vo, Eva Bagyinszky, Yoon Soo Park, John Hulme, Seong Soo A. An, An, Seong Soo A.

Abstract

Within the last two decades, several members of the Coronaviridae family demonstrated epidemic potential. In late 2019, an unnamed genetic relative, later named SARS-CoV-2 (COVID-19), erupted in the highly populous neighborhoods of Wuhan, China. Unchecked, COVID-19 spread rapidly among interconnected communities and related households before containment measures could be enacted. At present, the mortality rate of COVID-19 infection worldwide is 6.6%. In order to mitigate the number of infections, restrictions or recommendations on the number of people that can gather in a given area have been employed by governments worldwide. For governments to confidently lift these restrictions as well as counter a potential secondary wave of infections, alternative medications and diagnostic strategies against COVID-19 are urgently required. This review has focused on these issues.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 9%
Student > Master 3 9%
Researcher 3 9%
Professor 2 6%
Other 1 3%
Other 4 12%
Unknown 17 52%
Readers by discipline Count As %
Medicine and Dentistry 6 18%
Immunology and Microbiology 2 6%
Environmental Science 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 9%
Unknown 19 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2021.
All research outputs
#20,688,655
of 23,285,523 outputs
Outputs from Advances in experimental medicine and biology
#4,015
of 4,991 outputs
Outputs of similar age
#361,500
of 420,307 outputs
Outputs of similar age from Advances in experimental medicine and biology
#113
of 150 outputs
Altmetric has tracked 23,285,523 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,991 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,307 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.